A Louisiana resident has filed an Invokana lawsuit against Janssen Pharmaceuticals for failing to adequately warn about serious and dangerous risks associated with taking the diabetes drug, specifically the possibility of developing diabetic ketoacidosis and kidney failure.

Plaintiff Amber R. claims in her Invokana lawsuit that she developed ketoacidosis which led to kidney failure and other injuries from taking the drug in August 2015 to treat her type-2 diabetes.

Amber further alleges that the pharmaceutical companies willfully concealed their knowledge of Invokana’s unreasonably dangerous risks in order to prevent any chances that U.S. Food and Drug Administration (FDA) approval of Invokana would be delayed.

Amber claims she had relied on advertised claims that Invokana is a safe and effective treatment for type-2 diabetes, when, according to the Invokana lawsuit, the defendants knew or should have known the risks associated with the use of the diabetes medicine, including the risk of developing ketoacidosis and kidney failure.

About Invokana

Invokana (Invokamet) is a type-2 diabetes medicine manufactured by Janssen Research & Development, LLC. The drug is a SGLT2 inhibitor used in combination with diet and exercise to improve glycemic control and lower blood sugar in adults with type 2 diabetes mellitus.

Diabetes is a leading cause of death in the United States and leads to serious medical problems, including kidney failure, blindness, heart disease and other health issues.

Invokana was approved by the Food & Drug Administration in March 2013 for treatment of type-2 diabetes. However, in May 2015, the FDA warned in a safety communication that these drug treatments may put patients at risk for a serious health condition known as diabetic ketoacidosis.

Diabetic ketoacidosis occurs when the cells do not receive the glucose needed by the body for energy and the body begins to burn fat for energy, which produces ketones. When ketones build up in the blood, it becomes more acidic and can poison the body.

Diabetic ketoacidosis can lead to serious health problems, including diabetic coma. Other complications include heart attack, blood clots, and kidney failure.

Symptoms of Kidney Failure

Kidney failure is a potentially serious side-effect of the diabetes drug Invokana. The FDA warned in May 2015 that treatment with this medication can lead to diabetic ketoacidosis. This condition, if not timely treated or diagnosed, can lead to kidney failure.

There are many symptoms of acute kidney failure associated with diabetic ketoacidosis from patients taking Invokana including

• Bloody stools
• Breath odor and metallic taste in the mouth
• Changes in mental status or mood
• Decreased appetite
• Decreased sensation in the hands or feet
• Unusual fatigue
• Flank pain (between the ribs and hips)
• High blood pressure
• Prolonged nausea or vomiting
• Nosebleeds and prolonged bleeding
• Seizures
• Shortness of breath
• Slow, sluggish movements
• Swelling due to the body keeping in fluid (may be seen in the legs, ankles, and feet)
• Urination changes

Is an Invokana Lawsuit Right for You?

If you or someone you care about suffered kidney failure from taking this diabetes drug, you may be eligible to file an Invokana lawsuit.

Attorneys are currently investigating claims against the drug manufacturer by both patients and their families seeking compensation for injuries caused by Invokana. You may be entitled to a substantial settlement.

The Invokana Lawsuit is Case No. 5:16-cv-00666 in the U.S. District Court for the Western District of Louisiana.